Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FRESENIUS SE & CO. KGAA

(FRE)
  Rapport
Vertraagde tijd Xetra  -  17:35 05-10-2022
21.74 EUR   -3.59%
05/10Fresenius plant uitbreiding naar vroege nierzorg
MT
28/09Europese producenten van generieke geneesmiddelen zeggen dat ze hun productie kunnen verlagen vanwege de energierekening
MR
28/09Europese producenten van generieke geneesmiddelen verlagen mogelijk productie door stijgende energierekeningen
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Communiqués de presse de la société FRESENIUS SE & CO. KGAA
05/10Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Inj..
AQ
04/10Fresenius : Kabi expands contrast agent portfolio
PU
12/09Fresenius : Morgan Stanley – 20th Annual Global Healthcare Conference
PU
12/09Fresenius : 2023 DRG inflator for German hospitals set at 3.45 %
PU
07/09Benesch Healthcare+ Dialysis & Nephrology Digest No. 32
AQ
07/09Fresenius : Goldman Sachs – 19th Annual European Medtech and Healthcare Services Con..
PU
06/09Fresenius : Kabi receives U.S. FDA approval for biosimilar Stimufend®* (pegfilgrastim)
PU
05/09Fresenius : Commerzbank and ODDO BHF's annual Corporate Conference
PU
29/08Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
19/08Fresenius Se & Co. Kgaa : Michael Sen to succeed Stephan Sturm as CEO of Fresenius
EQ
09/08Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
08/08Fresenius : Kabi introduces 2D barcodes in the US
PU
05/08Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
05/08Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
04/08Fresenius : Factsheet H1/22 (PDF)
PU
02/08Fresenius : Q2/2022 Key Figures (XLSX)
PU
02/08Fresenius : publishes financial results for the second quarter and first half of 2022 in l..
PU
02/08Fresenius : publishes financial results for the second quarter and first half of 2022 in l..
PU
02/08Fresenius : Medical Care publishes financial results for the second quarter and first half..
PU
01/08Fresenius : Kabi's regulatory submission for tocilizumab biosimilar accepted for review by..
PU
01/08Fresenius : Kabi completes acquisition of majority stake in mAbxience
PU
01/08Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
AQ
29/07Fresenius : Kabi launches IV Drug in the U.S.
PU
28/07Fresenius : Conference Call Preliminary Q2/2022 Results
PU
28/07Fresenius : Conference Call Presentation
PU
27/07Fresenius Se & Co. Kgaa : Significantly worsening headwinds at Fresenius Medical Care impa..
EQ
27/07Fresenius : Q2/H12022 Kennzahlen (PDF)
PU
18/07Fresenius : Kabi launches its first generic contrast media agent in the U.S.
PU
13/07Fresenius Kabi - Romidepsin for Injection Available from Fresenius Kabi
AQ
12/07Fresenius : Kabi launches IV Drug in the U.S.
PU
23/06Fresenius : JP Morgan European Healthcare Conference
PU
13/06Fresenius : Company Presentation
PU
10/06Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
10/06Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
07/06Fresenius : Acceptance rate for scrip dividend of Fresenius reaches 40%
PU
01/06Fresenius Kabi Introduces PEMEtrexed for Injection, USP in the U.S.
AQ
31/05Fresenius : Kabi launches IV Drug in the U.S.
PU
24/05Fresenius Kabi - EuroPN Study, New clinical data on medical nutrition therapy in critic..
AQ
20/05Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
19/05Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
06/05Fresenius : Quarterly Financial Report Q1/22
PU
05/05Fresenius with solid start to 2022 despite macroeconomic challenges
AQ
05/05Fresenius Kabi Completes Acquisition of Ivenix
AQ
03/05Fresenius : Kabi launches IV Cancer Drug in the U.S.
PU
03/05Fresenius : Kabi prolongs the production and supply contract with Cerus Corporation for an..
PU
03/05Fresenius : Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Freseniu..
PU
28/04Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection in Ready-to-Ad..
AQ
27/04Fresenius : Kabi launches Calcium Gluconate in freeflex® bags in the U.S.
PU
04/04Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
31/03Fresenius Kabi receives European Commission approval for its pegfilgrastim biosimilar S..
AQ
31/03Fresenius : 2021 TCFD Index (PDF, 119 KB)
PU
31/03Fresenius : Conference Call on the acquisition of Ivenix and majority stake in mAbxience (..
PU
31/03Fresenius : Kabi buys a majority stake in mAbxience and acquires Ivenix
PU
30/03Fresenius Se & Co. Kgaa : Announcement of the Convening of the General Meeting on May 13,..
EQ
30/03Fresenius : Kabi receives European Commission approval for its pegfilgrastim biosimilar St..
PU
25/03Fresenius Kabi Announces FDA Approval of SMOFlipid Lipid Injectable Emulsion for Pediat..
AQ
24/03Fresenius : Annual Report 2021 (IFRS) (PDF, 12.61 MB)
PU
24/03Fresenius : Participations in affiliated and associated companies (PDF, 0.77 MB)
PU
21/03Fresenius : Medical Care participates in three-way merger to create premier value-based ki..
PU
18/03Fresenius : nominates Dr. Christoph Zindel for Supervisory Board
PU
15/03Fresenius : Virtual Roadshow Nordics
PU
14/03Fresenius : Kabi receives regulatory clearance from the FDA for infusion pump system
PU
24/02Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
22/02Fresenius : Conference Call FY 2021, Fresenius (PDF, 3.26 MB)
PU
14/02Fresenius : again has Germany's best online offering for job seekers, Potentialpark study ..
PU
17/01Fresenius Kabi is committed to achieving Net Zero emissions by 2045
AQ
10/01Fresenius : Helios acquires majority stake in U.S. fertility center
PU
04/01Fresenius : ODDO BHF Forum 2022
PU
03/01Fresenius : 40th Annual J.P. Morgan Healthcare Conference (PDF, 6.16 MB)
PU
03/01Fresenius : UniCredit Kepler Cheuvreux 21st German Corporate Conference (PDF, 6.16 MB)
PU
2021Fresenius : Kabi modernizes production facility in France
PU
2021Fresenius : again with top result in climate ranking
PU
2021Innovative EUR250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi
AQ
2021Fresenius : Medical Care's new FX CorAL dialyzer combines clinical performance with hemoco..
PU
2021Fresenius : Helios acquires oncological center and ophthalmic clinic in Colombia
PU
1  2  3  4  5  6Volgende
Volgende evenement op FRESENIUS SE & CO. KGAA